SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Jonasson Aino Fianu)
 

Sökning: WFRF:(Jonasson Aino Fianu) > (2015-2019) > Annual direct and i...

Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK

Weidlich, Diana (författare)
Catalyst Health Econ Consultants, England
Andersson, Fredrik L. (författare)
Linköpings universitet,Avdelningen för hälso- och sjukvårdsanalys,Medicinska fakulteten,Ferring Pharmaceut, Denmark,Center for Medical Technology Assessment, CMT
Oelke, Matthias (författare)
Hannover Medical Sch, Germany
visa fler...
John Drake, Marcus (författare)
Bristol Urol Institute, England
Fianu Jonasson, Aino (författare)
Karolinska Institutet,Karolinska Institute, Sweden
Guest, Julian F. (författare)
Catalyst Health Econ Consultants, England; Kings Coll London, England
visa färre...
 (creator_code:org_t)
2016-09-27
2017
Engelska.
Ingår i: European Journal of Health Economics. - : SPRINGER. - 1618-7598 .- 1618-7601. ; 18:6, s. 761-771
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Our aim was to estimate the prevalence-based cost of illness imposed by nocturia (a 2 nocturnal voids per night) in Germany, Sweden, and the UK in an average year. Information obtained from a systematic review of published literature and clinicians was used to construct an algorithm depicting the management of nocturia in these three countries. This enabled an estimation of (1) annual levels of healthcare resource use, (2) annual cost of healthcare resource use, and (3) annual societal cost arising from presenteeism and absenteeism attributable to nocturia in each country. In an average year, there are an estimated 12.5, 1.2, and 8.6 million patients a 20 years of age with nocturia in Germany, Sweden, and the UK, respectively. In an average year in each country, respectively, these patients were estimated to have 13.8, 1.4, and 10.0 million visits to a family practitioner or specialist, similar to 91,000, 9000, and 63,000 hospital admissions attributable to nocturia and 216,000, 19,000, and 130,000 subjects were estimated to incur a fracture resulting from nocturia. The annual direct cost of healthcare resource use attributable to managing nocturia was estimated to be approximately a,notsign2.32 billion in Germany, 5.11 billion kr (a,notsign0.54 billion) in Sweden, and A 1.35 pound billion (a,notsign1.77 billion) in the UK. The annual indirect societal cost arising from both presenteeism and absenteeism was estimated to be approximately a,notsign20.76 billion in Germany and 19.65 billion kr (a,notsign2.10 billion) in Sweden. In addition, in the UK, the annual indirect cost due to absenteeism was an estimated A 4.32 pound billion (a,notsign5.64 billion). Nocturia appears to impose a substantial socioeconomic burden in all three countries. Clinical and economic benefits could accrue from an increased awareness of the impact that nocturia imposes on patients, health services, and society as a whole.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskap -- Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Health Sciences -- Health Care Service and Management, Health Policy and Services and Health Economy (hsv//eng)

Nyckelord

Burden; Cost; Lower urinary tract symptoms; Nocturia; Germany; Sweden; UK

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy